Lack of renoprotective effect of chronic intravenous angiotensin-(1-7) or angiotensin-(2-10) in a rat model of focal segmental glomerulosclerosis

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Velez, Juan Carlos Q ^a,b   Janech, Michael G ^a   Hicks, Megan P ^a   Morinelli, Thomas A ^a   Rodgers, Jessalyn ^a   Self, Sally E ^a   Arthur, John M ^a,b   Fitzgibbon, Wayne R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN DERIVATIVE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN [1-7]; ANGIOTENSIN [2-10]; CAPTOPRIL; LOSARTAN; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; ANGIOTENSIN I; ANGIOTENSIN I (1-7); PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFECT; DRUG MEGADOSE; ESSENTIAL HYPERTENSION; FAWN HOODED HYPERTENSIVE RAT; FOCAL GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KIDNEY HOMOGENATE; KIDNEY INJURY; KIDNEY TUBULE DAMAGE; LOW DRUG DOSE; MALE; NONHUMAN; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEINURIA; RAT; RENAL PROTECTION; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; ANIMAL; COMPLICATION; DRUG ADMINISTRATION; DRUG EFFECTS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEK293 CELL LINE; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; NEPHRECTOMY; PATHOLOGY; PODOCYTE; RADIOASSAY; TREATMENT FAILURE;

RATTUS;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; DRUG ADMINISTRATION SCHEDULE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEK293 CELLS; HUMANS; HYPERTENSION; INJECTIONS, INTRAVENOUS; MALE; NEPHRECTOMY; PEPTIDE FRAGMENTS; PODOCYTES; RADIOLIGAND ASSAY; RATS; TREATMENT FAILURE;

EID: 84908283385     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110083     Document Type: Article

References (46)

1. Ibrahim HN, Rosenberg ME, Hostetter TH (1997) Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review. Seminars in nephrology 17: 431-440.
2. Colucci JA, Yuri Arita D, Sousa Cunha T, Seno Di Marco G, Vio CP, et al. (2011) Renin-angiotensin system may trigger kidney damage in NOD mice. Journal of the renin-angiotensin-aldosterone system: JRAAS 12: 15-22.
3. Fukuda A, Wickman LT, Venkatareddy MP, Sato Y, Chowdhury MA, et al. (2012) Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney international 81: 40-55.
4. Velez JC, Ryan KJ, Harbeson CE, Bland AM, Budisavljevic MN, et al. (2009) Angiotensin I is largely converted to angiotensin (1-7) and angiotensin (2-10) by isolated rat glomeruli. Hypertension 53: 790-797.
5. Velez JC, Bland AM, Arthur JM, Raymond JR, Janech MG (2007) Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes. American journal of physiology Renal physiology 293: F398-407.
6. Velez JC, Ierardi JL, Bland AM, Morinelli TA, Arthur JM, et al. (2012) Enzymatic processing of angiotensin peptides by human glomerular endothelial cells. American journal of physiology Renal physiology 302: F1583-1594.
7. Grobe N, Weir NM, Leiva O, Ong FS, Bernstein KE, et al. (2013) Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry. American journal of physiology Cell physiology 304: C945-953.
8. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proceedings of the National Academy of Sciences of the United States of America 100: 8258-8263.
9. Haulica I, Bild W, Mihaila CN, Ionita T, Boisteanu CP, et al. (2003) Biphasic effects of angiotensin (1-7) and its interactions with angiotensin II in rat aorta. Journal of the renin-angiotensin-aldosterone system: JRAAS 4: 124-128.
10. Simoes e Silva AC, Bello AP, Baracho NC, Khosla MC, Santos RA (1998) Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1-7) antagonist in normotensive and hypertensive rats. Regulatory peptides 74: 177-184.
11. Tallant EA, Ferrario CM, Gallagher PE (2005) Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. American journal of physiology Heart and circulatory physiology 289: H1560-1566.
12. Yoshida M, Naito Y, Urano T, Takada A, Takada Y (2002) L-158,809 and (D-Ala(7))-angiotensin I/II (1-7) decrease PAI-1 release from human umbilical vein endothelial cells. Thrombosis research 105: 531-536.
13. Giani JF, Burghi V, Veiras LC, Tomat A, Munoz MC, et al. (2012) Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats. American journal of physiology Renal physiology 302: F1606-1615.
14. Zhang J, Noble NA, Border WA, Huang Y (2010) Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. American journal of physiology Renal physiology 298: F579-588.
15. Dilauro M, Zimpelmann J, Robertson SJ, Genest D, Burns KD (2010) Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. American journal of physiology Renal physiology 298: F1523-1532.
16. van der Wouden EA, Henning RH, Deelman LE, Roks AJ, Boomsma F, et al. (2005) Does angiotensin (1-7) contribute to the anti-proteinuric effect of ACE-inhibitors. Journal of the renin-angiotensin-aldosterone system: JRAAS 6: 96-101.
17. Shao Y, He M, Zhou L, Yao T, Huang Y, et al. (2008) Chronic angiotensin (1-7) injection accelerates STZ-induced diabetic renal injury. Acta pharmacologica Sinica 29: 829-837.
18. Zimmerman D, Burns KD (2012) Angiotensin-(1-7) in kidney disease: a review of the controversies. Clinical science 123: 333-346.
19. Min L, Sim MK, Xu XG (2000) Effects of des-aspartate-angiotensin I on angiotensin II-induced incorporation of phenylalanine and thymidine in cultured rat cardiomyocytes and aortic smooth muscle cells. Regulatory peptides 95: 93-97.
20. Kemp BA, Bell JF, Rottkamp DM, Howell NL, Shao W, et al. (2012) Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors. Hypertension 60: 387-395.
21. Kuijpers MH, Gruys E (1984) Spontaneous hypertension and hypertensive renal disease in the fawn-hooded rat. British journal of experimental pathology 65: 181-190.
22. de Keijzer MH, Provoost AP, Molenaar JC (1989) Proteinuria is an early marker in the development of progressive renal failure in hypertensive fawn-hooded rats. Journal of hypertension 7: 525-528.
23. Kreisberg JI, Karnovsky MJ (1978) Focal glomerular sclerosis in the fawn-hooded rat. The American journal of pathology 92: 637-652.
24. Morinelli TA, Raymond JR, Baldys A, Yang Q, Lee MH, et al. (2007) Identification of a putative nuclear localization sequence within ANG II AT(1A) receptor associated with nuclear activation. American journal of physiology Cell physiology 292: C1398-1408.
25. Simons JL, Provoost AP, De Keijzer MH, Anderson S, Rennke HG, et al. (1993) Pathogenesis of glomerular injury in the fawn-hooded rat: effect of unilateral nephrectomy. Journal of the American Society of Nephrology: JASN 4: 1362-1370.
26. Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, et al. (2007) Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). American journal of physiology Heart and circulatory physiology 292: H736-742.
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. The Journal of biological chemistry 193: 265-275.
28. Lortie M, Bark S, Blantz R, Hook V (2009) Detecting low-abundance vasoactive peptides in plasma: progress toward absolute quantitation using nano liquid chromatography-mass spectrometry. Analytical biochemistry 394: 164-170.
29. Oliver JD 3rd, Simons JL, Troy JL, Provoost AP, Brenner BM, et al. (1994) Proteinuria and impaired glomerular permselectivity in uninephrectomized fawn-hooded rats. The American journal of physiology 267: F917-925.
30. Nishiyama A, Seth DM, Navar LG (2002) Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 39: 129-134.
31. Seikaly MG, Arant BS Jr, Seney FD Jr (1990) Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. The Journal of clinical investigation 86: 1352-1357.
32. Campbell DJ, Lawrence AC, Towrie A, Kladis A, Valentijn AJ (1991) Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension 18: 763-773.
33. Navar LG, Lewis L, Hymel A, Braam B, Mitchell KD (1994) Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats. Journal of the American Society of Nephrology: JASN 5: 1153-1158.
34. Prieto MC, Gonzalez-Villalobos RA, Botros FT, Martin VL, Pagan J, et al. (2011) Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats. American journal of physiology Renal physiology 300: F749-755.
35. Joyner J, Neves LA, Stovall K, Ferrario CM, Brosnihan KB (2008) Angiotensin-(1-7) serves as an aquaretic by increasing water intake and diuresis in association with downregulation of aquaporin-1 during pregnancy in rats. American journal of physiology Regulatory, integrative and comparative physiology 294: R1073-1080.
36. Handa RK, Ferrario CM, Strandhoy JW (1996) Renal actions of angiotensin-(1-7): in vivo and in vitro studies. The American journal of physiology 270: F141-147.
37. Ferrario CM, Varagic J (2010) The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function. American journal of physiology Renal physiology 298: F1297-1305.
38. Velkoska E, Dean RG, Griggs K, Burchill L, Burrell LM (2011) Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy. Clinical science 120: 335-345.
39. Benter IF, Yousif MH, Dhaunsi GS, Kaur J, Chappell MC, et al. (2008) Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. American journal of nephrology 28: 25-33.
40. Moon JY, Tanimoto M, Gohda T, Hagiwara S, Yamazaki T, et al. (2011) Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice. American journal of physiology Renal physiology 300: F1271-1282.
41. Zimpelmann J, Burns KD (2009) Angiotensin-(1-7) activates growth-stimulatory pathways in human mesangial cells. American journal of physiology Renal physiology 296: F337-346.
42. Benter IF, Diz DI, Ferrario CM (1993) Cardiovascular actions of angiotensin(1-7). Peptides 14: 679-684.
43. Benter IF, Ferrario CM, Morris M, Diz DI (1995) Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. The American journal of physiology 269: H313-319.
44. Ji H, Menini S, Zheng W, Pesce C, Wu X, et al. (2008) Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17beta-oestradiol regulation of renal pathology in renal wrap hypertension in rats. Experimental physiology 93: 648-657.
45. Bosnyak S, Jones ES, Christopoulos A, Aguilar MI, Thomas WG, et al. (2011) Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clinical science 121: 297-303.
46. Dhande I, Ali Q, Hussain T (2013) Proximal tubule angiotensin AT2 receptors mediate an anti-inflammatory response via interleukin-10: role in renoprotection in obese rats. Hypertension 61: 1218-1226.